| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1089-3261(02)00030-2 |
| P698 | PubMed publication ID | 12362573 |
| P2093 | author name string | Jayant A Talwalkar | |
| W Ray Kim | |||
| P2860 | cites work | Smoking and carcinoma of the lung; preliminary report | Q24676999 |
| A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 | ||
| What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes | Q29615705 | ||
| Gains in life expectancy from medical interventions--standardizing data on outcomes | Q32044932 | ||
| The geoepidemiology of primary biliary cirrhosis: contrasts and comparisons with the spectrum of autoimmune diseases | Q33607867 | ||
| Measurement of health state utilities for economic appraisal | Q33628526 | ||
| International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis | Q33784003 | ||
| Cholestatic liver diseases and health-related quality of life | Q33891059 | ||
| Quality of life measurement in gastrointestinal and liver disorders | Q34001406 | ||
| Estimability and estimation in case-referent studies | Q34169256 | ||
| Hepatic retransplantation in cholestatic liver disease: impact of the interval to retransplantation on survival and resource utilization | Q34210591 | ||
| A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease | Q34240518 | ||
| Low prevalence of primary biliary cirrhosis in Victoria, Australia. Melbourne Liver Group | Q34408189 | ||
| Primary biliary cirrhosis: geographical clustering and symptomatic onset seasonality | Q34496270 | ||
| Physical activity, obesity, height, and the risk of pancreatic cancer | Q34517072 | ||
| Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease | Q35356375 | ||
| Cancer risk in primary biliary cirrhosis: a study in northern England | Q35357912 | ||
| Chronic active hepatitis: a sixteen year survey at a district general hospital | Q36724217 | ||
| Incidence and prevalence of primary biliary cirrhosis in a defined population in Sweden | Q39317079 | ||
| Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England | Q39452020 | ||
| Utility approach to measuring health-related quality of life | Q39659272 | ||
| Sample size requirements in cohort and case-control studies of disease | Q39943374 | ||
| Cost of case-control studies | Q40356345 | ||
| Epidemiology and natural history of primary biliary cirrhosis in a US community | Q40735092 | ||
| Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis | Q40883127 | ||
| Measuring health-related quality of life | Q40885951 | ||
| When do the "dollars" make sense? Toward a conceptual framework for contingent valuation studies in health care | Q41119213 | ||
| Cost-benefit and cost-effectiveness analysis in health care. Growth and composition of the literature | Q41477854 | ||
| Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women | Q43646841 | ||
| The prevalence and clinical spectrum of primary biliary cirrhosis in a defined population. | Q43973385 | ||
| The "case-control" study: valid selection of subjects | Q44277220 | ||
| The demography of primary biliary cirrhosis in Ontario, Canada | Q44439436 | ||
| Oral contraceptives and breast cancer. A prospective cohort study | Q44446451 | ||
| Risk factors for primary biliary cirrhosis in a cohort of patients from the united states | Q44933098 | ||
| Prognosis in primary biliary cirrhosis: model for decision making | Q46316848 | ||
| Quality of life before and after liver transplantation for cholestatic liver disease | Q48773263 | ||
| Epidemiology of primary biliary cirrhosis in a defined rural population in the northern part of Sweden. | Q50553464 | ||
| Chronic Active Hepatitis in Sweden the Etiologic Spectrum, Clinical Presentation, and Laboratory Profile | Q50568876 | ||
| Epidemiology of primary biliary cirrhosis. | Q50588351 | ||
| Primary Biliary Cirrhosis in Estonia with Special Reference to Incidence, Prevalence, Clinical Features, and Outcome | Q50595131 | ||
| Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. | Q50628941 | ||
| Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis. | Q50636830 | ||
| Optimal timing of liver transplantation for primary biliary cirrhosis. | Q52240035 | ||
| Prevalence, incidence and duration. | Q52754239 | ||
| Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use. | Q52920374 | ||
| Reliability and validity of the NIDDK-QA instrument in the assessment of quality of life in ambulatory patients with cholestatic liver disease. | Q53509754 | ||
| Impact of fatigue on the quality of life of patients with primary biliary cirrhosis. | Q53527400 | ||
| Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. | Q54118475 | ||
| Familial primary biliary cirrhosis reassessed: a geographically-based population study | Q61633902 | ||
| Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study | Q68679742 | ||
| Chronic active hepatitis. Experience from a Norwegian reference hospital during a decade | Q69835126 | ||
| The incidence of chronic active hepatitis in Norway. A retrospective study | Q69835127 | ||
| Assessment of quality-of-life outcomes | Q70989734 | ||
| Primary biliary cirrhosis: an epidemiological study | Q71354203 | ||
| A 20-year prospective study of cirrhosis | Q71541228 | ||
| Economic assessments of medical practices and technologies | Q71647033 | ||
| Azathioprine for Long-Term Maintenance of Remission in Autoimmune Hepatitis | Q72039839 | ||
| Ursodeoxycholic acid in the treatment of primary biliary cirrhosis | Q72401649 | ||
| Chronic active hepatitis: the spectrum of disease | Q72520305 | ||
| Prescribing habits in primary biliary cirrhosis: a national survey | Q73065892 | ||
| Predicting clinical and economic outcomes after liver transplantation using the Mayo primary sclerosing cholangitis model and Child-Pugh score. National Institutes of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database Group | Q73204429 | ||
| Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver | Q73715566 | ||
| An exploratory population-based case-control study of primary biliary cirrhosis | Q73746110 | ||
| Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group | Q77807948 | ||
| Drug therapy in the management of type 1 autoimmune hepatitis | Q78023538 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 649-667 | |
| P577 | publication date | 2002-08-01 | |
| P1433 | published in | Clinics in liver disease | Q26842322 |
| P1476 | title | Medical and economic impact of autoimmune hepatitis | |
| P478 | volume | 6 |
| Q36716734 | Noninvasive classification of hepatic fibrosis based on texture parameters from double contrast-enhanced magnetic resonance images | cites work | P2860 |
Search more.